We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.35%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81.6B
AUM Growth
+$7.7B
(+10%)
Cap. Flow
+$798M
Cap. Flow
% of AUM
0.98%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
3,095
New
53
Increased
1,513
Reduced
1,408
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$65.3M |
| 2 |
Amazon
AMZN
|
+$50M |
| 3 |
Tesla
TSLA
|
+$30.5M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$26.6M |
| 5 |
EPAM Systems
EPAM
|
+$26.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KSU
Kansas City Southern
KSU
|
+$39.1M |
| 2 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$31.2M |
| 3 |
XEC
CIMAREX ENERGY CO
XEC
|
+$23.4M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$21.9M |
| 5 |
SBNY
Signature Bank
SBNY
|
+$17.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.54% |
| 2 | Financials | 13.15% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIBB
1726
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $2.68M | ﹤0.01% |
37,256
-764
| -2% | -$60.8K |
|
1727
Vir Biotechnology
VIR
$1.49B
| $2.67M | ﹤0.01% |
63,854
-480
| -0.7% | -$18.8K |
|
|
HA
1728
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.67M | ﹤0.01% |
145,279
-21
| -0% | -$425 |
|
1729
PDF Solutions
PDFS
$2.07B
| $2.67M | ﹤0.01% |
83,858
-368
| -0.4% | -$10.2K |
|
1730
Arcus Biosciences
RCUS
$3.64B
| $2.65M | ﹤0.01% |
65,417
-86
| -0.1% | -$3.34K |
|
1731
Certara
CERT
$1.25B
| $2.65M | ﹤0.01% |
93,111
+23,418
| +34% | +$788K |
|
|
QVCGA
1732
DELISTED
QVC Group Inc Series A
QVCGA
| $2.65M | ﹤0.01% |
6,964
-8
| -0.1% | -$3.62K |
|
1733
Vanda Pharmaceuticals
VNDA
$302M
| $2.65M | ﹤0.01% |
168,566
-2,743
| -2% | -$47.8K |
|
|
FSR
1734
DELISTED
Fisker Inc.
FSR
| $2.64M | ﹤0.01% |
167,861
-2,428
| -1% | -$42K |
|
|
DMC
1735
Del Monte Corp
DMC
$1.45B
| $2.63M | ﹤0.01% |
95,140
-750
| -0.8% | -$22.1K |
|
|
BBBY
1736
Bed Bath & Beyond
BBBY
$442M
| $2.61M | ﹤0.01% |
48,727
-1,480
| -3% | -$112K |
|
1737
PC Connection
CNXN
$2.12B
| $2.61M | ﹤0.01% |
60,590
+356
| +0.6% | +$16.1K |
|
1738
Chord Energy
CHRD
$7.39B
| $2.61M | ﹤0.01% |
20,689
-461
| -2% | -$54.8K |
|
1739
Winmark
WINA
$1.32B
| $2.61M | ﹤0.01% |
10,499
-53
| -0.5% | -$12.8K |
|
1740
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $2.6M | ﹤0.01% |
68,349
-1,014
| -1% | -$38.5K |
|
|
VIVO
1741
DELISTED
Meridian Bioscience Inc
VIVO
| $2.58M | ﹤0.01% |
126,390
+1,778
| +1% | +$34.1K |
|
|
ATSG
1742
DELISTED
Air Transport Services Group
ATSG
| $2.57M | ﹤0.01% |
87,592
-1,231
| -1% | -$32.7K |
|
1743
Iovance Biotherapeutics
IOVA
$2.87B
| $2.57M | ﹤0.01% |
134,519
+4,603
| +4% | +$101K |
|
|
VMEO
1744
DELISTED
Vimeo
VMEO
| $2.56M | ﹤0.01% |
142,670
+7,544
| +6% | +$184K |
|
|
AXNX
1745
DELISTED
Axonics, Inc. Common Stock
AXNX
| $2.55M | ﹤0.01% |
45,582
-111
| -0.2% | -$6.78K |
|
1746
National Healthcare
NHC
$3.38B
| $2.54M | ﹤0.01% |
37,332
-218
| -0.6% | -$15.1K |
|
1747
Children's Place
PLCE
$59.8M
| $2.53M | ﹤0.01% |
31,921
-2,119
| -6% | -$186K |
|
1748
Magnite
MGNI
$3.55B
| $2.53M | ﹤0.01% |
144,463
+5,906
| +4% | +$133K |
|
|
PGRE
1749
DELISTED
Paramount Group
PGRE
| $2.53M | ﹤0.01% |
303,048
-4,634
| -2% | -$41.1K |
|
1750
Heritage Financial
HFWA
$1.21B
| $2.52M | ﹤0.01% |
103,249
-585
| -0.6% | -$14.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2021 Portfolio in Review
As of Q4 2021, RhumbLine Advisers held 3,095 positions worth $81.6B, up 10% from $73.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 4.4%. RhumbLine Advisers opened 53 new positions and exited 84, leaving the 3,095-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2021 buy was Rivian: 125,331 shares worth $13M.
- RhumbLine Advisers added most to Microsoft in Q4 2021, an estimated $65.3M increase.
- RhumbLine Advisers's biggest Q4 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $21.9M.
- RhumbLine Advisers fully exited Kansas City Southern in Q4 2021, selling an estimated $39.1M.
- RhumbLine Advisers's ten largest holdings make up 24% of its $81.6B portfolio in Q4 2021.
- RhumbLine Advisers opened 53 new positions and closed 84 in Q4 2021.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $81.6B.
Based on RhumbLine Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.